Quarterly report · Q2
1783.TEDINET S100TFQF
Period2023-10-01 → 2024-03-31
Filed2024-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.0bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥10.6bn | 2022-10-01 → 2023-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.0bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | ¥54m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥1.4bn | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥40m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.5bn | 2022-10-01 → 2023-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥118m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.4bn | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥73m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.1bn | 2022-10-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.0bn | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥73m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥1.0bn | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥8.4bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥7.5bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥7.4bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.0bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.1bn | at 2023-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.4bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.4bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.4bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.8bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.6bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.7bn | at 2022-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥2.7bn | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.7bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.3bn | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥109m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥230m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥68m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.4bn | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥656m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥896m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥0.43 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.68 | 2024-01-01 → 2024-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥6.21 | 2022-10-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥6.09 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.14 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥5.96 | 2022-10-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 75.8% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.8% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.2% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-03-31 | −¥44m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-03-31 | −¥44m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥304m |
| jpcrp040300-q2r_E00263-000Healthcare Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥277m |
| jpcrp040300-q2r_E00263-000Healthcare Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥233m |
| jpcrp040300-q2r_E00263-000Healthcare Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥44m |
| jpcrp040300-q2r_E00263-000Healthcare Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥52m |
| jpcrp040300-q2r_E00263-000Real Estatereportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥4.8bn |
| jpcrp040300-q2r_E00263-000Real Estatereportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥4.8bn |
| jpcrp040300-q2r_E00263-000Real Estatereportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥313m |
| jpcrp040300-q2r_E00263-000Real Estate Consulting Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥19m |
| jpcrp040300-q2r_E00263-000Real Estate Consulting Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥19m |
| jpcrp040300-q2r_E00263-000Real Estate Consulting Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥8m |
| —segment total | revenue | 2023-10-01 → 2024-03-31 | ¥5.1bn |
| —segment total | revenue external | 2023-10-01 → 2024-03-31 | ¥5.0bn |
| —segment total | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥44m |
| —segment total | segment profit | 2023-10-01 → 2024-03-31 | ¥357m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥209m |
| jpcrp040300-q2r_E00263-000Healthcare Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥296m |
| jpcrp040300-q2r_E00263-000Healthcare Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥296m |
| jpcrp040300-q2r_E00263-000Healthcare Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥6m |
| jpcrp040300-q2r_E00263-000Real Estatereportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥4.6bn |
| jpcrp040300-q2r_E00263-000Real Estatereportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥4.6bn |
| jpcrp040300-q2r_E00263-000Real Estatereportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥1.6bn |
| jpcrp040300-q2r_E00263-000Real Estate Consulting Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥16m |
| jpcrp040300-q2r_E00263-000Real Estate Consulting Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥16m |
| jpcrp040300-q2r_E00263-000Real Estate Consulting Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥25m |
| —segment total | revenue | 2022-10-01 → 2023-03-31 | ¥5.0bn |
| —segment total | revenue external | 2022-10-01 → 2023-03-31 | ¥5.0bn |
| —segment total | segment profit | 2022-10-01 → 2023-03-31 | ¥1.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 516
| Item | Context | Value | Unit |
|---|---|---|---|
| Provision for bonuses | Prior1YearInstant | 10867000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 5658000 | JPY |
| Provision for shareholder benefit program cl | Prior1YearInstant | 64783000 | JPY |
| Provision for shareholder benefit program cl | CurrentQuarterInstant | - | JPY |
| Other cl | Prior1YearInstant | 61401000 | JPY |
| Other cl | CurrentQuarterInstant | 53844000 | JPY |
| Current liabilities | Prior1YearInstant | 1053383000 | JPY |
| Current liabilities | CurrentQuarterInstant | 1099194000 | JPY |
| Long term loans payable | Prior1YearInstant | 3772000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 843396000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 1409000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | - | JPY |
| Provision for directors retirement benefits | Prior1YearInstant | - | JPY |
| Provision for directors retirement benefits | CurrentQuarterInstant | 17775000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 24000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 216000 | JPY |
| Long term deposits received | Prior1YearInstant | 35700000 | JPY |
| Long term deposits received | CurrentQuarterInstant | 35700000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 29687000 | JPY |
| Asset retirement obligations ncl | CurrentQuarterInstant | 29789000 | JPY |
| Other ncl | Prior1YearInstant | 20094000 | JPY |
| Other ncl | CurrentQuarterInstant | 17292000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 90688000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 944169000 | JPY |
| Liabilities | Prior1YearInstant | 1144072000 | JPY |
| Liabilities | CurrentQuarterInstant | 2043363000 | JPY |
| Capital stock | Prior1YearInstant | 6633604000 | JPY |
| Capital stock | CurrentQuarterInstant | 6633604000 | JPY |
| Capital surplus | Prior1YearInstant | 4652655000 | JPY |
| Capital surplus | CurrentQuarterInstant | 4652655000 | JPY |
| Retained earnings | Prior1YearInstant | -4962911000 | JPY |
| Retained earnings | CurrentQuarterInstant | -4890277000 | JPY |
| Treasury stock | Prior1YearInstant | -41000 | JPY |
| Treasury stock | CurrentQuarterInstant | -43000 | JPY |
| Shareholders equity | Prior1YearInstant | 6323306000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 6395938000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 78642000 | JPY |
| Subscription rights to shares | CurrentQuarterInstant | 2318000 | JPY |
| Net assets | Prior1YearInstant | 6401948000 | JPY |
| Net assets | CurrentQuarterInstant | 6398256000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 7546020000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 8441619000 | JPY |
| Net sales | Prior1YTDDuration | 4957497000 | JPY |
| Net sales | CurrentYTDDuration | 5018139000 | JPY |
| Cost of sales | Prior1YTDDuration | 2841725000 | JPY |
| Cost of sales | CurrentYTDDuration | 4215976000 | JPY |
| Gross profit | Prior1YTDDuration | 2115772000 | JPY |
| Gross profit | CurrentYTDDuration | 802163000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 715358000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 748493000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |